DE69433817D1 - Lineare und cyklische peptide zur behandlung oder vorbeugung der crohn'schen krankheit und/oder der ulzerativen kolitis - Google Patents

Lineare und cyklische peptide zur behandlung oder vorbeugung der crohn'schen krankheit und/oder der ulzerativen kolitis

Info

Publication number
DE69433817D1
DE69433817D1 DE69433817T DE69433817T DE69433817D1 DE 69433817 D1 DE69433817 D1 DE 69433817D1 DE 69433817 T DE69433817 T DE 69433817T DE 69433817 T DE69433817 T DE 69433817T DE 69433817 D1 DE69433817 D1 DE 69433817D1
Authority
DE
Germany
Prior art keywords
crohn
colitis
ultrasound
disease
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69433817T
Other languages
English (en)
Other versions
DE69433817T2 (de
Inventor
Jurgen Michaelis
Merilyn Joy Sleigh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Immuni T Inc
Original Assignee
Advanced Immuni T Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Immuni T Inc filed Critical Advanced Immuni T Inc
Application granted granted Critical
Publication of DE69433817D1 publication Critical patent/DE69433817D1/de
Publication of DE69433817T2 publication Critical patent/DE69433817T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69433817T 1993-09-24 1994-09-26 Lineare und cyklische peptide zur behandlung oder vorbeugung der crohn'schen krankheit und/oder der ulzerativen kolitis Expired - Fee Related DE69433817T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM144893 1993-09-24
AUPM144893 1993-09-24
PCT/AU1994/000575 WO1995008339A1 (en) 1993-09-24 1994-09-26 Treatment or prevention of crohn's disease and/or ulcerative colitis

Publications (2)

Publication Number Publication Date
DE69433817D1 true DE69433817D1 (de) 2004-07-01
DE69433817T2 DE69433817T2 (de) 2005-07-14

Family

ID=3777228

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433817T Expired - Fee Related DE69433817T2 (de) 1993-09-24 1994-09-26 Lineare und cyklische peptide zur behandlung oder vorbeugung der crohn'schen krankheit und/oder der ulzerativen kolitis

Country Status (8)

Country Link
US (1) US5795858A (de)
EP (1) EP0729360B1 (de)
JP (1) JP3499562B2 (de)
AU (1) AU7735194A (de)
DE (1) DE69433817T2 (de)
DK (1) DK0729360T3 (de)
ES (1) ES2220915T3 (de)
WO (1) WO1995008339A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3681542B2 (ja) * 1998-07-01 2005-08-10 富士通株式会社 プリント回路基板および多段バンプ用中継基板
US6297015B1 (en) * 1998-09-24 2001-10-02 Ira Shafran Crohn's disease diagnostic and treatment methods and compositions
PT2364360T (pt) 2008-11-13 2017-06-27 Nogra Pharma Ltd Composições em sentido reverso e métodos de as fabricar e utilizar

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
ATE96450T1 (de) * 1986-06-03 1993-11-15 Us Commerce Kleine peptide, die die bindung an t-4-rezeptoren inhibieren und als immunogene wirken.
US6242564B1 (en) * 1986-06-03 2001-06-05 Candace B. Pert Treatment of tropical spastic paresis with peptide T
AU7544987A (en) * 1986-06-03 1988-01-11 Pert, C.B. Small peptides which inhibit binding to t-4 receptors
WO1988009338A1 (en) * 1987-05-22 1988-12-01 Syntbiotech, Inc. Synthetic peptides and a method of treating aids
US5189022A (en) * 1988-05-27 1993-02-23 The United States Of America As Represented By The Secretary Of Health And Human Services Composition for the treatment of chronic fatigue syndrome
US5063206A (en) * 1988-12-16 1991-11-05 The United States Of Americas As Represented By The Department Of Health And Human Services Compositions having use as treatment of neuropsychiatric deficits
JPH0618777B2 (ja) * 1988-05-27 1994-03-16 アメリカ合衆国 精神神経性欠損症の治療に用いられる組成物
DK0635027T3 (da) * 1992-03-27 2000-10-02 Advanced Immunit T Inc Peptid T og beslægtede peptider til behandling af inflammation, herunder dissemineret sclerose
WO1995015179A1 (en) * 1993-12-01 1995-06-08 Unisearch Limited Method of treating intestinal disorders

Also Published As

Publication number Publication date
EP0729360A1 (de) 1996-09-04
EP0729360A4 (de) 1998-11-11
EP0729360B1 (de) 2004-05-26
JPH09502971A (ja) 1997-03-25
ES2220915T3 (es) 2004-12-16
US5795858A (en) 1998-08-18
DE69433817T2 (de) 2005-07-14
AU7735194A (en) 1995-04-10
DK0729360T3 (da) 2004-09-27
WO1995008339A1 (en) 1995-03-30
JP3499562B2 (ja) 2004-02-23

Similar Documents

Publication Publication Date Title
DE4497905T1 (de) Pharmazeutische Zusammensetzung zur Prävention und Behandlung des Motion-Sickness-Syndroms
DE69117117D1 (de) Reinigungszusammensetzung zur Vorbeugung und Milderung von Hautreizungen
FI941826A (fi) Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi
BR9407799A (pt) Composição de matéria método de tratamento e composição farmaceutica
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DE69332732D1 (de) Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
DE19580261D2 (de) Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion
DE69423961T2 (de) Stauchbehandlung von flexiblen warenbahnen
DE69429101T2 (de) Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
DE69627780D1 (de) Peptid das eine Immunantwort gegen menschlichen Magenkrebs induziert und Arzneimittel die es enthält zur Vorbeugung oder Behandlung von Magenkrebs
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69625883T2 (de) Zusammensetzung zur Reinigung und/oder Desinfektion von medizinischen Geräten
DE69433817D1 (de) Lineare und cyklische peptide zur behandlung oder vorbeugung der crohn'schen krankheit und/oder der ulzerativen kolitis
FI944561A0 (fi) HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV-infektion ehkäisemiseksi ja hoitamiseksi
DE69418931T2 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
DE59309732D1 (de) Arzneimittel zur behandlung und prophylaxe von knochen- und gelenkserkrankungen
KR950701812A (ko) 렌티바이러스-유도된 질환의 치료에 유용한 생물학적으로 활성인 우레이도 유도체(Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease)
DE69433763D1 (de) Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis
EP0653208A3 (de) Substanz P Antagonisten zur Behandlung oder Verhütung des sonnenbrandes.
ATE224711T1 (de) Formulierung zur behandlung und/oder vorbeugung von dementia
IT1246296B (it) Procedimento di estrzione e purificazione del gamma interferone umano ricombinante
ITRM930183A1 (it) Sostanze in gel o crema per esaltare l'effetto del trattamento di terapia estetica e apparecchiatura relativa per l'applicazione
DE59408477D1 (de) Therapieeinrichtung zur behandlung von leiden des herzens und herznaher gefässe
DE69431103D1 (de) Injizierbares implantat zur behandlungen von falten und hautdepressionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee